본문 바로가기
KERD
논문KCI 등재

음성진전 유무에 따른 내전형 연축성 발성장애의 보툴리눔 독소-A 주입 후 음성 특성 변화 양상

The Aspect of Voice Characteristics Change after Botulinum Toxin-A Injection in Patients with Adductor Spasmodic Dysphonia according to Vocal Tremor

1

조회

0

다운로드

2

인용

0

참고문헌

키워드

주제분류학제간연구

초록

As BTX-A, which has been known to be the most effective treatment for ADSD, is not effective in treating vocal tremors,voice assessment must be employed to perform differential diagnosis of SD and vocal tremor in an accurate fashion. In this study, the characteristics of vocal changes after botulinum toxin injection were compared by analyzing the voice characteristics resulting from the presence of vocal tremors using objective analysis devices, with the aim of helping to provide prognoses and to determine remedial effects in clinical cases comprising patients with adductor spasmodic dysphonia accompanied by voice tremors. Respiratory function tests, aerodynamic analysis, electroglottography (EGG), acoustic analysis, auditory perception tests,and K-VHI had been conducted at intervals of four, eight, and twelve weeks before and after injection, targeting a group of 17ADSD female patients (a ADSD group of four with vocal tremor and a ADSD group of 13 without voice tremor). For average FVC and FEV1, the T group showed statistically significant low averages compared with the NT group, whereas the T group showed statistically significant high average ATRI compared with the NT group. In addition, the T group showed a statistically significant Fatr, lower than that of the NT group. For the ADSD group of patients with voice tremor, their vocal tremor remained unchanged despite noticeable decrease in wringing voices. In other words, as the vocal tremor and wringing voices are two distinctive features, there is a need for the two features to be targeted separately for differential diagnosis.

Abstract

As BTX-A, which has been known to be the most effective treatment for ADSD, is not effective in treating vocal tremors,voice assessment must be employed to perform differential diagnosis of SD and vocal tremor in an accurate fashion. In this study, the characteristics of vocal changes after botulinum toxin injection were compared by analyzing the voice characteristics resulting from the presence of vocal tremors using objective analysis devices, with the aim of helping to provide prognoses and to determine remedial effects in clinical cases comprising patients with adductor spasmodic dysphonia accompanied by voice tremors. Respiratory function tests, aerodynamic analysis, electroglottography (EGG), acoustic analysis, auditory perception tests,and K-VHI had been conducted at intervals of four, eight, and twelve weeks before and after injection, targeting a group of 17ADSD female patients (a ADSD group of four with vocal tremor and a ADSD group of 13 without voice tremor). For average FVC and FEV1, the T group showed statistically significant low averages compared with the NT group, whereas the T group showed statistically significant high average ATRI compared with the NT group. In addition, the T group showed a statistically significant Fatr, lower than that of the NT group. For the ADSD group of patients with voice tremor, their vocal tremor remained unchanged despite noticeable decrease in wringing voices. In other words, as the vocal tremor and wringing voices are two distinctive features, there is a need for the two features to be targeted separately for differential diagnosis.

참고문헌 (36)

  1. Aronson, A. E., "spastic dysphonia. Comparison with Eessential(voice)tremor and other neurologic and psychogenidystonias", J SpeechHear Disord, 33, pp.219~31 (1968)
  2. Aronson, A. E., "Botulinum toxin injection for adductor spastic dysphonia : patient self-ratings of voice and phonatory effort after threesuccessive injections", Laryngoscope, 103(6), pp.683~92 (1993)
  3. Barkmeier, J. M., "Identificationof symptoms for spasmodic dysphonia and vocal tremor : acomparison of expert and nonexpert judges", J Commun Disord, 34(1), pp.21~37 (2001)
  4. Blitzer, A., "Laryngeal dystonia : A series withbotulinum in therapy", Ann Otol Rhinol Laryngol, 100, pp.85~89 (1991)
  5. Blitzer, A., "Botulinum toxinmanagement of spasmodic dysphonia : a 12-year experience inmore than 900 patients", Laryngoscope, 108, pp.1435~441 (1998)
  6. Brin, M. F., "Movement disorders of the larynx, In Neurologic disorders of the larynx" (1992), Thieme
  7. Brown, J. R., "Organic voice tremor : Atremor of phonation", Neurology, 13, pp.520~25 (1963)
  8. Cantarella, G., "Botulinum toxin injection and airflow stability inspasmodic dysphonia", Otolaryngol Head Neck Surg, 134(3), pp.419~23 (2006)
  9. 최홍식, "연축성 발성장애 환자의 음향학적 및 공기역학적 양상", 대한음성언어의학회지, 11(1), pp.98~103 (2000)
  10. 최재남, "일측성 성대마비와 성대구증의 성문면적파형과 발성 특성 비교", Communication Sciences and Disorders, 12(3), pp.487~507 (2007), 한국언어청각임상학회
  11. 최성희, "파킨슨증의 음성진전 : 감별진단을 위한 예비연구", 음성과학, 12(3), pp.2~2 (2005), 한국음성과학회
  12. Crevier-Buchman, L. C., "Adductor spasmodic dysphonia(Case reports withacoustic analysis following botulinum toxin injection andacupuncture)", J Voice, 11(2), pp.232~237 (1997)
  13. Djarmati, A., "Mutations in THAP1(DYT6)and generalised dystonia with prominent spasmodic dysphonia : a genetic screening study", Lancet Neurol, 28(5), pp.416~418 (2009)
  14. 황연신, "내전형 연축성 발성장애의 연속 발화 특성", 말소리와 음성과학, 1(1), pp.93~98 (2009), 한국음성학회
  15. 정성민, "연축성 발성장애의 원인 및 진단", 대한음성언어의학회지, 13(1), pp.65~71 (2002)
  16. 김재옥, "한국어판 음성장애지수와 음성관련 삶의 질의 타당도 및 신뢰도 연구", 음성과학, 14(3), pp.111~125 (2007), 한국음성과학회
  17. 김재옥, "한국 정상 성인 음성의Phonatory Analysis System을 이용한 공기역학적 특성 분석", 제1회 한국언어치료학회·한국언어청각임상학회 공동학술대회, pp.82~86 (2009)
  18. Kendall, K. A., "Interarytenoid musclebotox injection for tretment of adductor spasmodic dysphoniawith vocal tremor", J Voice, 25(1), pp.114~119 (2011)
  19. Kent, R. D., "Maximumperformance tests of speech production", Journal of SpeechHear Res, 52, pp.367~387 (1987)
  20. Laura, J., "Coprevalence of tremor with SapsmodicDysphonia : A Case-Control Study", Laryngoscope, 121, pp.1752~1755 (2011)
  21. Ludlow, C., "Phonatorycharacteristics of vocal fold tremor", Journal of phonetics, 14, pp.509~515 (1986)
  22. Ludlow, C. L., "Research priorities inspasmodic dysphonia", Otolaryngol Head Neck Surgery, 139(4), pp.495~505 (2008)
  23. Ludlow, C. L., "Treatment for spasmodic dysphonia : limitation of current approaches", Curr Opin Otolaryngol HeadNeck Surg, 17(3), pp.160~165 (2009)
  24. 남도현, "내전형 경련성발성장애의 호흡압력과 공기역학적 특징", 음성과학, 12(4), pp.16~16 (2005), 한국음성과학회
  25. 남도현, "호흡과 발성" (2007), 군자출판사
  26. Paul, Warrick., "Botulinumtoinfor essential tremor of the voice with multiple anatomical sitesof tremor : A crossover Design study of unilateral versusbilateral injection", Laryngoscope, 110(8), pp.1366~1374 (2000)
  27. 박선영, "연축성발성장애의 청지각적 평가 및 공기역학적 특성", 대한음성언어의학회지, 19(1), pp.38~42 (2008)
  28. Pearson, E. J., "Historical approaches tothe treatment of Adductor-Type Spasmodic dysphonia(ADSD):review and tutorial", Neuro Rehabilitation, 18(4), pp.325~338 (2003)
  29. Peng, Y., "Spasmodicdysphonia in a patient with the A to G transition at nucleotide8344 in mitochondrial DNA", Mov Disor, 18(6), pp.716~718 (2003)
  30. Swashima, M., "Measurements of the phonation time", JapJournal of Logopedphoniatr, 7, pp.23~29 (1966)
  31. Swenson, M. R., "Medical evaluation of patients with spasmodicdysphonia", J Voice, 6(4), pp.320~324 (1992)
  32. Tucker, H. M., "Combination surgical therapy for spasmodicdysphonia", J voice, 6, pp.355~357 (1992)
  33. 양윤수, "연축성 발성장애", 대한이비인후과학회지 두경부외과학, 53(9), pp.519~526 (2010), 대한이비인후과학회
  34. Yamazaki, R., "Epidemiological investigation in spasmodicdysphonia-Investigation by questionaire", Japan Journal ofLogopedics and Phoniatrics, 42, pp.343~47 (2001)
  35. 윤보람, "내전형 연축성 발성장애 환자의 보툴리눔 독소-A 주입술 전후의 음성특성 비교", 대한이비인후과학회지 두경부외과학, 54(02), pp.148~153 (2011), 대한이비인후과학회
  36. Zwirner, P., "Acoustic changes spasmodic dysphonia after botulinum toxininjections", J Voice, 5(1), pp.78~84 (1991)

관련 논문AI추천

이 간행물의 다른 논문 (15건)